ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis
USA - NASDAQ:OSUR - US68554V1089 - Common Stock
2.31 USD
+0.03 (+1.32%)
2.31 USD
0 (0%)
Overall OSUR gets a fundamental rating of 2 out of 10. We evaluated OSUR against 189 industry peers in the Health Care Equipment & Supplies industry. OSUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSUR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
OSUR had negative earnings in the past year.
In the past year OSUR has reported a negative cash flow from operations.
OSUR had negative earnings in 4 of the past 5 years.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of OSUR (-14.24%) is comparable to the rest of the industry.
OSUR has a Return On Equity of -16.64%. This is in the better half of the industry: OSUR outperforms 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROIC | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 40.41%, OSUR is not doing good in the industry: 66.14% of the companies in the same industry are doing better.
OSUR's Gross Margin has declined in the last couple of years.
OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
2. Health
2.1 Basic Checks
OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSUR has more shares outstanding
OSUR has more shares outstanding than it did 5 years ago.
OSUR has a better debt/assets ratio than last year.
2.2 Solvency
OSUR has an Altman-Z score of 1.61. This is a bad value and indicates that OSUR is not financially healthy and even has some risk of bankruptcy.
OSUR's Altman-Z score of 1.61 is in line compared to the rest of the industry. OSUR outperforms 57.14% of its industry peers.
OSUR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
OSUR has a Debt to Equity ratio of 0.00. This is in the better half of the industry: OSUR outperforms 75.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.61 |
ROIC/WACCN/A
WACC8.74%
2.3 Liquidity
OSUR has a Current Ratio of 7.03. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.03, OSUR belongs to the top of the industry, outperforming 86.24% of the companies in the same industry.
OSUR has a Quick Ratio of 6.20. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR has a better Quick ratio (6.20) than 87.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 |
3. Growth
3.1 Past
The earnings per share for OSUR have decreased strongly by -633.33% in the last year.
Looking at the last year, OSUR shows a very negative growth in Revenue. The Revenue has decreased by -43.95% in the last year.
Measured over the past years, OSUR shows a small growth in Revenue. The Revenue has been growing by 3.75% on average per year.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
3.2 Future
The Earnings Per Share is expected to grow by 25.37% on average over the next years. This is a very strong growth
OSUR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.62% yearly.
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OSUR's earnings are expected to decrease with -41.36% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
5. Dividend
5.1 Amount
OSUR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.31
+0.03 (+1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners92.79%
Inst Owner Change-1.03%
Ins Owners4.8%
Ins Owner Change8.23%
Market Cap168.95M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts82.5
Price Target6.12 (164.94%)
Short Float %5.52%
Short Ratio7.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)5%
EPS NQ rev (3m)-11.76%
EPS NY rev (1m)-3.57%
EPS NY rev (3m)-16.78%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)-14.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.34 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.47 | ||
| P/tB | 0.56 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS1.72
BVpS4.95
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% | ||
| FCFM | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 36.29% | ||
| Cap/Sales | 2.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 | ||
| Altman-Z | 1.61 |
F-Score2
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-100.55%
EBIT Next 3Y14.36%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%
ORASURE TECHNOLOGIES INC / OSUR FAQ
What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OSUR.
Can you provide the valuation status for ORASURE TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.
Can you provide the profitability details for ORASURE TECHNOLOGIES INC?
ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.
How financially healthy is ORASURE TECHNOLOGIES INC?
The financial health rating of ORASURE TECHNOLOGIES INC (OSUR) is 5 / 10.